Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases
Open accessThe DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Most of our current knowledge about cellular phenotypes in neurodevelopmental and neurodegenerative diseases in humans was gathered from studies in postmortem brain tissues. These samples often represent the end-stage of the disease and therefore are not always a fair representation of how the disease developed. Moreover, under these circumstances, the pathology observed could be a secondary effect rather than the authentic disease cellular phenotype. Likewise, the rodent models available do not always recapitulate the pathology from human diseases. In this review, we will examine recent literature on the use of induced pluripotent stem cells to model neurodegenerative and neurodevelopmental diseases. We highlight the characteristics of diseases like spinal muscular atrophy and familial dysautonomia that allowed partial modeling of the disease phenotype. We review human stem cell literature on common neurodegenerative late-onset diseases such as Parkinson's disease and amyotrophic lateral sclerosis where patients' cells have been successfully reprogrammed but a disease phenotype has not yet been described. So far, the technique is of great interest for early onset monogenetic neurodevelopmental diseases. We speculate about potential further experimental requirements and settings for reprogrammed neurons for in vitro disease modeling and drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · cited 1×
“Yamanaka’s original reprogramming experiment surprised the scientific community by overturning the dogma that specialized cells in the body retain an immutable identity (1).”
BackgroundEmbryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1529 · Cited by 3,620
Direct conversion of fibroblasts to functional neurons by defined factors
Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Südhof, T. C., & Wernig, M. (2010) · Nature · doi:10.1038/nature08797 · Cited by 3,017 · cited 1×
“Technology is already available to generate functionally active, cortical-like mouse neurons from differentiated cells without the need for complete reprogramming to iPSC (45,46).”
BackgroundHuman induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196 · cited 3×
“Huntington’s disease Not shown (3) Rett syndrome”
BackgroundDimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. (2008) · Science · doi:10.1126/science.1153252 · Cited by 1,823
Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins
Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.04.005 · Cited by 1,788
Research works printed but not linked: 2
- 2000, 28, 31
- 2007, 56, 422
Cited by
Marchetto, M. C. N., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., Chen, G., Gage, F. H., & Muotri, A. R. (2010) · Cell · doi:10.1016/j.cell.2010.10.016 · Cited by 1,329
Self-citationNeural Stem Cells: Generating and Regenerating the Brain
Gage, F. H., & Temple, S. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.037 · Cited by 574
Self-citationDirect reprogramming of mouse fibroblasts to neural progenitors
Kim, J., Efe, J. A., Zhu, S., Talantova, M., Yuan, X., Wang, S., Lipton, S. A., Zhang, K., & Ding, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103113108 · Cited by 572
Espuny-Camacho, I., Michelsen, K. A., Gall, D., Linaro, D., Hasche, A., Bonnefont, J., Bali, C., Orduz, D., Bilheu, A., Herpoel, A., et al. (2013) · Neuron · doi:10.1016/j.neuron.2012.12.011 · Cited by 568
Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro
Bardy, C., van den Hurk, M., Eames, T., Marchand, C., Hernandez, R. V., Kellogg, M., Gorris, M., Galet, B., Palomares, V., Brown, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504393112 · Cited by 429
Self-citationTranslation of Human-Induced Pluripotent Stem Cells
Sayed, N., Liu, C., & Wu, J. C. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.083 · Cited by 279
Lin, M., Pedrosa, E., Shah, A., Hrabovsky, A., Maqbool, S., Zheng, D., & Lachman, H. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023356 · Cited by 242
Induced Pluripotent Stem Cells as a Disease Modeling and Drug Screening Platform
Ebert, A. D., Liang, P., & Wu, J. C. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318247f642 · Cited by 222
The Use of Induced Pluripotent Stem Cells in Drug Development
Inoue, H., & Yamanaka, S. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.38 · Cited by 221
Mitne-Neto, M., Machado-Costa, M., Marchetto, M. C. N., Bengtson, M. H., Joazeiro, C. A., Tsuda, H., Bellen, H. J., Silva, H. C. A., Oliveira, A. S. B., Lazar, M., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr284 · Cited by 214
Self-citationEffects of neuroinflammation on the regenerative capacity of brain stem cells
Russo, I., Barlati, S., & Bosetti, F. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07168.x · Cited by 156
Da Silveira Paulsen, B., De Moraes Maciel, R., Galina, A., Da Silveira, M. S., Souza, C. D. S., Drummond, H., Pozzatto, E. N., Junior, H. S., Chicaybam, L., Massuda, R., et al. (2012) · Cell Transplantation · doi:10.3727/096368911x600957 · Cited by 162
Autophagy in Stem Cell Maintenance and Differentiation
Vessoni, A. T., Muotri, A. R., & Okamoto, O. K. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0526 · Cited by 143
Epigenetics of early-life lead exposure and effects on brain development
Senut, M.-C., Cingolani, P., Sen, A., Kruger, A., Shaik, A., Hirsch, H., Suhr, S. T., & Ruden, D. (2012) · Epigenomics · doi:10.2217/epi.12.58 · Cited by 151
Tang, X., Zhou, L., Wagner, A. M., Marchetto, M. C. N., Muotri, A. R., Gage, F. H., & Chen, G. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.05.002 · Cited by 137
Self-citationBoissart, C., Poulet, A., Georges, P., Darville, H., Julita, E., Delorme, R., Bourgeron, T., Peschanski, M., & Benchoua, A. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.71 · Cited by 128
Development of Patient-Specific Neurons in Schizophrenia Using Induced Pluripotent Stem Cells
Pedrosa, E., Sandler, V., Shah, A., Carroll, R., Chang, C., Rockowitz, S., Guo, X., Zheng, D., & Lachman, H. M. (2011) · Journal of Neurogenetics · doi:10.3109/01677063.2011.597908 · Cited by 129
Neurotrophic Natural Products: Chemistry and Biology
Xu, J., Lacoske, M. H., & Theodorakis, E. A. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302268 · Cited by 131
Vishwakarma, S. K., Bardia, A., Tiwari, S. K., Paspala, S. A. B., & Khan, A. A. (2013) · Journal of Advanced Research · doi:10.1016/j.jare.2013.04.005 · Cited by 113
The role of DNA repair in the pluripotency and differentiation of human stem cells
Rocha, C. R. R., Lerner, L. K., Okamoto, O. K., Marchetto, M. C., & Menck, C. F. M. (2013) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.09.001 · Cited by 92
Self-citationiPS cells to model CDKL5-related disorders
Amenduni, M., De Filippis, R., Cheung, A. Y. L., Disciglio, V., Epistolato, M. C., Ariani, F., Mari, F., Mencarelli, M. A., Hayek, Y., Renieri, A., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.131 · Cited by 85
Human pluripotent stem cell–derived models and drug screening in CNS precision medicine
Silva, M. C., & Haggarty, S. J. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14012 · Cited by 83
Stem Cell Technology for the Study and Treatment of Motor Neuron Diseases
Lunn, J. S., Sakowski, S. A., Federici, T., Glass, J. D., Boulis, N. M., & Feldman, E. L. (2011) · Regenerative Medicine · doi:10.2217/rme.11.6 · Cited by 77
Srikanth, P., & Young-Pearse, T. L. (2014) · Journal of Neurogenetics · doi:10.3109/01677063.2014.881358 · Cited by 57
Hippocampal Neurogenesis, Cognitive Deficits and Affective Disorder in Huntington's Disease
Ransome, M. I., Renoir, T., & Hannan, A. J. (2012) · Neural Plasticity · doi:10.1155/2012/874387 · Cited by 64
Neural stem cells: mechanisms and modeling
Yao, J., Mu, Y., & Gage, F. H. (2012) · Protein & Cell · doi:10.1007/s13238-012-2033-6 · Cited by 69
Self-citationGenes and environments in schizophrenia: The different pieces of a manifold puzzle
Réthelyi, J., Benkovits, J., & Bitter, I. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.010 · Cited by 67
The Pharmacology of Regenerative Medicine
Christ, G. J., Saul, J. M., Furth, M. E., & Andersson, K. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007393 · Cited by 65
In vitro models of axon regeneration
Al‐Ali, H., Beckerman, S. R., Bixby, J. L., & Lemmon, V. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.01.020 · Cited by 64
Babos, K. N., Galloway, K. E., Kisler, K., Zitting, M., Li, Y., Shi, Y., Quintino, B., Chow, R. H.-P., Zloković, B. V., & Ichida, J. K. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.08.005 · Cited by 61
hiPSC-derived neural stem cells from patients with schizophrenia induce an impaired angiogenesis
Casas, B. S., Vitória, G., do Costa, M. N., da Costa, R. M., Trindade, P., Maciel, R. D. M., Nelson Navarrete, N., Rehen, S. K., & Palma, V. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0095-9 · Cited by 61
iPSC-derived neurons as a higher-throughput readout for autism: promises and pitfalls
Prilutsky, D., Palmer, N. P., Smedemark-Margulies, N., Schlaeger, T. M., Margulies, D. M., & Kohane, I. S. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.11.004 · Cited by 48
Next‐generation disease modeling with direct conversion: a new path to old neurons
Traxler, L., Edenhofer, F., & Mertens, J. (2019) · FEBS Letters · doi:10.1002/1873-3468.13678 · Cited by 56
Stem cells for brain repair in neonatal hypoxia–ischemia
Chicha, L., Smith, T. N., & Guzman, R. G. (2013) · Child s Nervous System · doi:10.1007/s00381-013-2304-4 · Cited by 54
Pluripotent Stem Cells for the Study of CNS Development
Petros, T. J., Tyson, J. A., & Anderson, S. A. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00030 · Cited by 44
In vitro neurogenesis: development and functional implications of iPSC technology
Compagnucci, C., Nizzardo, M., Corti, S. P., Zanni, G., & Bertini, E. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1511-1 · Cited by 50
Stem Cells asIn VitroModel of Parkinson's Disease
Martínez‐Morales, P., & Liste, I. (2012) · Stem Cells International · doi:10.1155/2012/980941 · Cited by 51
Modeling neurodevelopmental disorders using human neurons
Chailangkarn, T., Acab, A., & Muotri, A. R. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.04.004 · Cited by 43
Stem cell biology and drug discovery
Rubin, L. L., & Haston, K. M. (2011) · BMC Biology · doi:10.1186/1741-7007-9-42 · Cited by 49
Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic
Miniarikova, J., Evers, M. M., & Konstantinova, P. S. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.002 · Cited by 49
Patient-Specific Pluripotent Stem Cells in Neurological Diseases
Durnaoglu, S., Genç, Ş., & Genç, K. (2011) · Stem Cells International · doi:10.4061/2011/212487 · Cited by 47
Tidball, A. M., & Parent, J. M. (2015) · Stem Cells · doi:10.1002/stem.2203 · Cited by 47
Klapper, S. D., Garg, P., Dagar, S., Lenk, K., Gottmann, K., & Nieweg, K. (2019) · Glia · doi:10.1002/glia.23666 · Cited by 41
Pediatric psychopharmacology: Too much or too little?
Rapoport, J. L. (2013) · World Psychiatry · doi:10.1002/wps.20028 · Cited by 44
Modeling autism spectrum disorders with human neurons
Beltrão-Braga, P. C. B., & Muotri, A. R. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.057 · Cited by 44
The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk
Kumar, K. K., Aboud, A. A., & Bowman, A. B. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.02.005 · Cited by 44
Addington, A. M., & Rapoport, J. L. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02478.x · Cited by 44
Impact of induced pluripotent stem cells on the study of central nervous system disease
Cundiff, P. E., & Anderson, S. A. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.01.008 · Cited by 37
In Vitro 3D Modeling of Neurodegenerative Diseases
Louit, A., Galbraith, T., & Berthod, F. (2023) · Bioengineering · doi:10.3390/bioengineering10010093 · Cited by 41
Urraca, N., Memon, R., El-Iyachi, I., Goorha, S., Valdez, C., Tran, Q. T., Scroggs, R. S., Miranda‐Carboni, G. A., Donaldson, M., Bridges, D., et al. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.11.004 · Cited by 41
Acharya, M. M., Martirosian, V., Christie, L., Riparip, L., Strnádel, J., Parihar, V. K., & Limoli, C. L. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0063 · Cited by 40
Bell, S., Peng, H., Crapper, L., Kolobova, I., Maussion, G., Vasuta, C., Yerko, V., Wong, T. P., & Ernst, C. (2016) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0158 · Cited by 39
Vizlin‐Hodzic, D., Zhai, Q., Illes, S., Södersten, K., Truvé, K., Parris, T. Z., Sobhan, P. K., Salmela, S., Kosalai, S. T., Kanduri, C., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.284 · Cited by 37
Dandulakis, M. G., Meganathan, K., Kroll, K. L., Bonni, A., & Constantino, J. N. (2016) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-016-9155-8 · Cited by 36
Culturing and Neuronal Differentiation of Human Dental Pulp Stem Cells
Goorha, S., & Reiter, L. T. (2017) · Current Protocols in Human Genetics · doi:10.1002/cphg.28 · Cited by 35
Modeling Cell-Cell Interactions in Parkinson’s Disease Using Human Stem Cell-Based Models
Simmnacher, K., Lanfer, J., Rizo, T., Kaindl, J., & Winner, B. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00571 · Cited by 35
Self-citationQuantitative proteomic analysis of Rett iPSC-derived neuronal progenitors
Varderidou‐Minasian, S., Hinz, L., Hagemans, D., Posthuma, D., Altelaar, M. A. F., & Heine, V. M. (2020) · Molecular Autism · doi:10.1186/s13229-020-00344-3 · Cited by 34
SSEA4-Positive Pig Induced Pluripotent Stem Cells are Primed for Differentiation into Neural Cells
Yang, J., Mumaw, J. L., Liu, Y., Stice, S. L., & West, F. D. (2013) · Cell Transplantation · doi:10.3727/096368912x657279 · Cited by 33
Choline Ameliorates Disease Phenotypes in Human iPSC Models of Rett Syndrome
Chin, E., Marcy, G., Yoon, S.-I., Ma, D., Rosales, F. J., Augustine, G. J., & Goh, E. L. K. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8421-y · Cited by 34
Induced Pluripotent Stem Cells to Model and Treat Neurogenetic Disorders
Wang, H., & Doering, L. C. (2012) · Neural Plasticity · doi:10.1155/2012/346053 · Cited by 32
From Single Genes to Gene Networks: High-Throughput-High-Content Screening for Neurological Disease
Jain, S., & Heutink, P. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.010 · Cited by 32
Engineering cell fate: Applying synthetic biology to cellular reprogramming
Wang, N., Beitz, A. M., & Galloway, K. E. (2020) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2020.09.002 · Cited by 30
Induced pluripotent stem cells as a next-generation biomedical interface
Hankowski, K. E., Hamazaki, T., Umezawa, A., & Terada, N. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.85 · Cited by 30
Varun, D., Srinivasan, G. R., Tsai, Y.-H., Kim, H.-J., Cutts, J., Petty, F. J., Merkley, R., Stephanopoulos, N., Bohačiaková, D., Maršala, M., et al. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.10.037 · Cited by 28
Massa, M. G., Gisevius, B., Hirschberg, S., Hinz, L., Schmidt, M., Gold, R., Prochnow, N., & Haghikia, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155274 · Cited by 27
Maternal genotype influences behavioral development of 3×Tg-AD mouse pups
Blaney, C., Gunn, R. K., Stover, K. R., & Brown, R. E. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.05.033 · Cited by 27
Stem Cells for the Treatment of Neurodegenerative Diseases
Wu, Y., Chen, W., Teng, C., & Zhang, N. (2010) · Molecules · doi:10.3390/molecules15106743 · Cited by 27
Brafman, D. A. (2014) · Methods in molecular biology · doi:10.1007/7651_2014_90 · Cited by 26
Paulsen, B. D. S., Silveira, M. S., Galina, A., & Rehen, S. K. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.10.009 · Cited by 25
In vitro-differentiated neural cell cultures progress towards donor-identical brain tissue
Hjelm, B. E., Salhia, B., Kurdoglu, A., Szelinger, S., Reiman, R. A., Sue, L. I., Beach, T. G., Huentelman, M. J., & Craig, D. W. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt208 · Cited by 22
Tsai, Y.-H., Cutts, J., Kimura, A., Varun, D., & Brafman, D. A. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.05.002 · Cited by 25
Induction of pluripotent stem cells from autopsy donor-derived somatic cells
Hjelm, B. E., Rosenberg, J. B., Szelinger, S., Sue, L. I., Beach, T. G., Huentelman, M. J., & Craig, D. W. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.048 · Cited by 25
Modeling Retinal Dystrophies Using Patient-Derived Induced Pluripotent Stem Cells
Wahlin, K. J., Maruotti, J., & Zack, D. J. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3209-8_20 · Cited by 24
Capturing Alzheimer's disease genomes with induced pluripotent stem cells: prospects and challenges
Israel, M. A., & Goldstein, L. S. B. (2011) · Genome Medicine · doi:10.1186/gm265 · Cited by 24
Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC‐Based Models
Fernández‐Santiago, R., & Ezquerra, M. (2015) · Stem Cells International · doi:10.1155/2016/9464591 · Cited by 24
Novel Tools, Classic Techniques: Evolutionary Studies Using Primate Pluripotent Stem Cells
Hrvoj-Mihić, B., Marchetto, M. C., Gage, F. H., Semendeferi, K., & Muotri, A. R. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.08.007 · Cited by 23
Self-citationGreat Expectations: Autism Spectrum Disorder and Induced Pluripotent Stem Cell Technologies
Liu, E. Y., & Scott, C. T. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9497-0 · Cited by 20
Martinez, Y., Dubois‐Dauphin, M., & Krause, K. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00047 · Cited by 20
iPSC modeling of rare pediatric disorders
Freel, B. A., Sheets, J. N., & Francis, K. R. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.108533 · Cited by 20
Neurotrophe Naturstoffe – ihre Chemie und Biologie
Xu, J., Lacoske, M. H., & Theodorakis, E. A. (2013) · Angewandte Chemie · doi:10.1002/ange.201302268 · Cited by 18
Correlated random walks of human embryonic stem cells in vitro
Wadkin, L. E., Orozco-Fuentes, S., Neganova, I. E., Swan, G., Laude, A., Lako, M., Shukurov, A., & Parker, N. G. (2018) · Physical Biology · doi:10.1088/1478-3975/aac008 · Cited by 18
Zuccoli, G. S., Nascimento, J. M., Codo, A. C., Moraes-Vieira, P. M., Rehen, S. K., & Martins‐de‐Souza, D. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01605-x · Cited by 17
Pluripotent Stem Cells Models for Huntington's Disease: Prospects and Challenges
Carter, R. L., & Chan, A. W. S. (2012) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2012.04.006 · Cited by 17
Singh, S., Srivastava, A., Srivastava, P., Dhuriya, Y. K., Pandey, A., Kumar, D., & Rajpurohit, C. S. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00072 · Cited by 16
Amirbekyan, M., Adhikarla, V., B, J. P. C. A., Moschonas, E. H., Bondi, C. O., Rockne, R. C., Kline, A. E., & Gutova, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-44426-7 · Cited by 15
Inducing pluripotency for disease modeling, drug development and craniofacial applications
Rosa, V., Toh, W. S., Cao, T., & SHIM, W. S. N. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.915306 · Cited by 13
Combining Patient-Reprogrammed Neural Cells and Proteomics as a Model to Study Psychiatric Disorders
Zuccoli, G. S., Martins‐de‐Souza, D., Guest, P. C., Rehen, S. K., & Nascimento, J. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-52479-5_26 · Cited by 13
Recovery of Motor Function Following Spinal Cord Injury
Fuller, H. R., & Gates, M. A. (2016) · InTech eBooks · doi:10.5772/61539 · Cited by 12
Myelin disorders and stem cells: as therapies and models
Aydınlı, F. İ., Çelik, E., Vatandaşlar, B. K., & Kerman, B. E. (2016) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1512-83 · Cited by 12
Modeling complex neuropsychiatric disease with induced pluripotent stem cells
Ross, P. J., & Ellis, J. (2010) · F1000 Biology Reports · doi:10.3410/b2-84 · Cited by 12
Bak, A., Schmied, K., Jakob, M., Bedogni, F., Squire, O. A., Gittel, B., Jesinghausen, M., Schünemann, K. D., Weber, Y. G., Kampa, B. M., et al. (2024) · Journal of Neurophysiology · doi:10.1152/jn.00178.2024 · Cited by 11
Brain Organoid Generation from Induced Pluripotent Stem Cells in Home-Made Mini Bioreactors
Eremeev, A., Belikova, L. D., Ruchko, E. S., Volovikov, E. A., Zubkova, O., Emelin, A., Deev, R. V., Lebedeva, O., Bogomazova, A., & Lagarkova, M. A. (2021) · Journal of Visualized Experiments · doi:10.3791/62987 · Cited by 11
Culturing and Neuronal Differentiation of Human Dental Pulp Stem Cells
Goorha, S., Victor, A. K., & Reiter, L. T. (2022) · Current Protocols · doi:10.1002/cpz1.600 · Cited by 11
Novel Paths Towards Neural Cellular Products for Neurological Disorders
Daadi, M. M. (2011) · Regenerative Medicine · doi:10.2217/rme.11.85 · Cited by 10
Células-tronco pluripotentes e doenças neurológicas
Muotri, A. R. (2010) · Estudos Avançados · doi:10.1590/s0103-40142010000300005 · Cited by 10
In search of lost time: age and the promise of induced pluripotent stem cell models of the brain
Milne, R. (2016) · New Genetics and Society · doi:10.1080/14636778.2016.1257934 · Cited by 10
Silva, M. C., Nandi, G., & Haggarty, S. J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1979-7_10 · Cited by 9
Targeted Microinjection and Electroporation of Primate Cerebral Organoids for Genetic Modification
Tynianskaia, L., Eşiyok, N., Huttner, W. Β., & Heide, M. (2023) · Journal of Visualized Experiments · doi:10.3791/65176 · Cited by 9
Gene Therapy for Rett Syndrome: Prospects and Challenges
Gadalla, K. K. E., Ross, P. D., Hector, R. D., Bahey, N. G., Bailey, M. E. S., & Cobb, S. (2015) · Future Neurology · doi:10.2217/fnl.15.29 · Cited by 9
Romito, E., Battistella, I., Plakhova, V. B., Paplekaj, A., Forastieri, C., Toffolo, E., Musio, C., Conti, L., Battaglioli, E., & Rusconi, F. (2024) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2024.110225 · Cited by 7
Metadata
- Authors
- Marchetto, M. C. N., Winner, B., & Gage, F. H.
- Affiliations
- Salk Institute for Biological Studies (US)
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-15
- Volume
- 19
- Issue
- R1
- Pages
- R71-R76
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC2875052
- OpenAlex
- W2167639593
- Cited by
- 152
- References
- 85
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 8 · 2018: 7 · 2017: 7 · 2016: 21 · 2015: 9 · 2014: 14 · 2013: 23 · 2012: 14
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Human Molecular Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Christopher and Dana Reeve Foundation
- Alexander von Humboldt-Stiftung
- California Institute of Regenerative Medicine
- G. Harold and Leila Y. Mathers Foundation
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- induced pluripotent stem cells, disease modeling, neurodegenerative diseases, neurodevelopmental disorders, spinal muscular atrophy, familial dysautonomia, Parkinson's disease, amyotrophic lateral sclerosis, in vitro disease model, drug discovery
- MeSH terms
- Drug Evaluation, Preclinical, Humans, Neurodegenerative Diseases, Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.